This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

ANI Pharmaceuticals Inc (ANIP)

NASDAQ: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Cash and Equivalents 11.10M 34.79M 57.23M 38.16M
Receivables 12.51M 0.00 0.00 0.00
Inventories 3.52M 0.00 0.00 0.00
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 27.72M 35.17M 58.03M 40.63M
Property, Plant & Equipment, Gross 7.73M 557.95K 1.29M 1.08M
Accumulated Depreciation & Depletion 3.20M 391.56K 426.09K 445.85K
Property, Plant & Equipment, Net 4.54M 166.39K 861.36K 635.78K
Intangibles 10.41M 0.00 0.00 0.00
Other Non-Current Assets 0.00 3.43M 3.49M 3.51M
Total Non-Current Assets 16.78M 3.60M 4.35M 4.14M
Liabilities & Shareholder Equity
Total Assets 44.50M 38.77M 62.38M 44.77M
Accounts Payable 1.43M 1.13M 3.15M 4.86M
Short Term Debt 0.00 0.00 0.00 1.11M
Other Current Liabilities 736.00K 0.00 0.00 0.00
Total Current Liabilities 3.54M 10.59M 7.23M 8.18M
Long Term Debt 0.00 0.00 17.34M 17.44M
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 0.00 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 0.00 0.00 17.34M 17.44M
Total Liabilities 3.54M 10.59M 24.56M 25.62M
Preferred Stock Equity 0.00 391.00 391.00 391.00
Common Stock Equity 40.96M 28.18M 37.81M 19.15M
Common Par 1.00K 273.13M 255.05M 184.78M
Additional Paid In Capital 89.50M 0.00 0.00 0.00
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -48.47M -244.96M -217.24M -165.63M
Treasury Stock -68.00K 0.00 0.00 0.00
Other Equity Adjustments 0.00 0.00 0.00 0.00
Total Capitalization 40.96M 28.18M 55.15M 36.58M
Total Equity 40.96M 28.18M 37.82M 19.15M
Total Liabilities & Stock Equity 44.50M 38.77M 62.38M 44.77M
Total Common Shares Outstanding 9.63M 4.14M 3.44M 2.65M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 9.23K 0.00 0.00 0.00
Basic Weighted Shares Outstanding 5.07M 3.63M 2.73M 1.83M
Diluted Weighted Shares Outstanding 5.07M 3.63M 2.73M 1.83M
Number of Employees 81 12 54 45
Number of Part-Time Employees 0 0 0 0

ANIP ANI Pharmaceuticals Inc

Analysts Ratings for ANIP

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 2 2 2 2
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

Brokerage Partners

ANIP Chatter

Select the service that is right for you!

Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs